July 2024
M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Blog

Aug 4, 2023, 09:15

10 Tweets from ASCOBT23 not to miss

ASCO Breakthrough (ASCOBT23) is being held in Yokohama, Japan, and online from August 3 to 5, 2023, co-hosted by the Japan Society of Clinical Oncology (JSCO) and the Japanese Society of Medical Oncology (JSMO). OncoDaily has collected 10 important posts from the first two days of ASCOBT23.

1. Melvin LK Chua, Chair of the ASCO Asia Pacific Regional Council and Chair-elect of ASCO Breakthrough Program

Inspiring opening address by Rakuten Group CEO Hiroshi (Mickey) Mikitani on entrepreneurship and how that could lead to breakthroughs in Cancer chaired by Lillian Siu.

Quote of the day: 2 choices in life – to do or not to do! And not doing is not an option!

Photo from Melvin LK Chua’s Twitter

2. Julie Gralow, Chief Medical Officer of the American Society of Clinical Oncology

ASCO Asia Pacific Regional Council meeting at ASCOBT23. Such a terrific group of leaders from the region!

Photo from Julie Gralow’s Twitter

3. Lynn M. Schuchter, President of ASCO

All star panel on novel therapeutics ASCO Breakthrough meeting from ADCs, BITES to vaccines. Anthony Tolcher ask the provocative? Are we in an ADC bubble? More than half the audience said yes. He also recommended a must read book Anatomy of Breakthrough.

Photo from Lynn Schuchter’s Twitter

4. Annie Wong, Medical Oncologist, Senior lecturer at the University Otago Wellington, New Zealand

🤩Exciting global research from Dr Chloe Atreya on the impact of microbiome on 5FU therapeutics

🤔Could this explain poor tolerance of capecitabine in 🌎 whereas very manageable in New Zealand and Australia.

Photo from Annie Wong’s Twitter

5. Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong

Thrilled to have our very own Grace Wong of Chinese University of Hong Kong take to the stage at ASCOBT23 showcasing the role of artificial intelligence for early detection of hepatocellular carcinoma and sharing her team’s experience in Hong Kong. Large volume of work has been put in to improve modelling and accuracy.

Photo from Herbert Loong’s Twitter

6. David D. W. Lee, Consultant clinical oncologist at the University of Malaya, Kuala Lumpur, Malaysia

Love the closing for this session.
Are you ready for AI?
My answer is YES.

‘AI will not replace oncologists.
Oncologists who use AI will replace those who don’t.’

Photo from David D. W. Lee’s Twitter

7. Julie Gralow, Chief Medical Officer of the American Society of Clinical Oncology

ASCO President Lynn Schuchter presents presidents of the Japanese Society of Medical Oncology and Japanese Society of Clinical Oncology with pens made of oak from US Capitol to represent the strength of our relationship at ASCOBT23.

Photo from Julie Gralow’s Twitter

8. Khalid El Bairi, Founder of The Cancer Biomarkers Working Group, ASCO Trainee & Early Career Advisory Group Member

I made it !
My first onsite ASCO meeting made possible because of the great support of the Conquer Cancer Foundation.

Photo from Khalid El Bairi’s Twitter

9. Roupen Odabashian, Hematology/Oncology Fellow at Karmanos Cancer Institute

It is a very Exciting Breakthrough in Lung cancer to witness how Deep Learning and AI can help to detect YAP1-activated drug-tolerant persister cells during targeted therapy for lung cancer leading to personalized treatments and better outcomes.